Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kesios Therapeutics Ltd.

www.kesios.com

Latest From Kesios Therapeutics Ltd.

Appointments: Bayer, Mustang, Modus, GammaDelta, Poxel, Metrion and Renova.

This week's roundup includes CEO appointments by various companies including Mustang Bio, GammaDelta and Modus Therapeutics and other high-level appointments by Bayer, Renova, Metrion and Poxel.

Appointments BioPharmaceutical

Venture Funding Deals, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.

BioPharmaceutical Medical Device

Big Pharma's Executive Brain Drain Benefits Biotech

Big Pharma has provided its executives with unrivaled stability, opportunity, and financial rewards, but swelling numbers are fleeing corporate offices for tiny biotechs. A blip in good times for biotech or a sea change for the industry?

Big Pharma's Executive Brain Drain Benefits Biotech

Big Pharma has provided its executives with unrivaled stability, opportunity, and financial rewards, but swelling numbers are fleeing corporate offices for tiny biotechs. A blip in good times for biotech or a sea change for the industry?

BioPharmaceutical Leadership
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Kesios Therapeutics Ltd.
  • Senior Management
  • Jane Robertson, MD, CMO
    Peter Charlton, CSO
    Dayle Hogg, COO
    Margaret Daniel, Dir., Fin.
  • Contact Info
  • Kesios Therapeutics Ltd.
    Phone: 203 818 9280
    Imperial College Incubator, Bessemer Bld
    Levels 1&2
    London, SW7 2AZ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register